Roswell Biotechnologies
San Diego
About Roswell Biotechnologies
Roswell Biotechnologies is a molecular electronics company transforming DNA sequencing with their latest platform, designed to deliver the disruptive performance required for future biomedical and industrial applications. The platform technology, ENDSeq™ (Electronic Nano-Device Sequencing), deploys single molecule sensor nanotechnology in a scalable semiconductor chip format, to deliver a dramatic reduction in the cost of genome-sequencing with unprecedented speed, accuracy and simplicity. Roswell is focused on delivering the molecular electronics chip and system that provides a $100, 1-hour whole human genome for use in precision medicine.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $37.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2019)
- Website: roswellbiotech.com
- Phone: 858 333 7995
Industries & Categories
Biotechnology, Electronics, Health Care
Social Profiles
Canonical: https://fsome.com/organization/roswell-biotechnologies-66363 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.